StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.36−0.20 (-2.65%)

Close on Nov 16, 2026Market cap $643.98MP/E –Yield –

Olema Oncology total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

No total debt figures for Olema Oncology

Olema Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Olema Oncology figures

See a number that looks wrong?